Concordia International Corp. (CXR.TO)


Toronto - Toronto Delayed Price. Currency in CAD
5.87-0.12 (-2.00%)
At close: 3:59 PM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open6.01
Prev Close5.99
Bid5.87 x
Ask5.88 x
Day's Range5.85 - 6.24
52wk Range5.80 - 60.55
1y Target EstN/A
Market Cap299.47M
P/E Ratio (ttm)-0.44
Beta2.94
Volume567,607
Avg Vol (3m)842,433
Dividend & Yield0.39 (1.44%)
Earnings DateN/A
  • Capital Cube8 days ago

    ETF’s with exposure to Concordia International Corp. : September 22, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Concordia International Corp. Here are 5 ETF’s with the largest exposure to CXR-CA. Comparing the performance and risk of Concordia International Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • PR Newswire15 days ago

    Concordia International Comments on Health Service Medical Supplies (Costs) Bill

    OAKVILLE, ON, Sept. 16, 2016 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (CXRX) (CXR.TO), an international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs, today commented on the UK's Health Service Medical Supplies (Costs) Bill, which was introduced into the House of Commons on September 15, 2016. "Concordia is supportive of any action that provides patients with greater access to safe and efficacious medicines," said Mark Thompson, Chairman and Chief Executive Officer of Concordia. "We anticipate that growth from our international segment, which includes the UK market, going forward will primarily come from new product launches.

  • CNW Group15 days ago

    Concordia International Comments on Health Service Medical Supplies (Costs) Bill

    Concordia International Comments on Health Service Medical Supplies (Costs) Bill